Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider before making changes to your health regimen. Sources include the American Heart Association, National Institutes of Health, and peer-reviewed medical journals.
I thought I knew my cholesterol numbers. I really did. Every year for the past decade, I sit in Dr. Patel's office, she reads me the LDL, HDL, and triglyceride numbers off her screen, I nod like I understand what they mean, and she tells me to eat more vegetables. It's a ritual. It's comforting. It's also apparently been missing a critical piece of information that could determine whether I drop dead of a heart attack in my 50s.
The test is called Lp(a) — pronounced "L-P-little-a" — and as of this week, new medical guidelines from an expert panel are recommending that every adult get screened for it at least once in their lifetime. Multiple major outlets, including NPR, The New York Times, and CNN, reported the guideline change on March 13, and the medical community is calling it one of the most significant shifts in cardiovascular risk assessment in decades.
What Is Lp(a) and Why Haven't You Heard of It?
Lipoprotein(a) is a type of cholesterol particle that's genetically determined — meaning you can't lower it with diet, exercise, or even most existing medications. Unlike LDL cholesterol, which fluctuates based on what you eat and how much you move, your Lp(a) level is essentially set at birth. It stays remarkably stable throughout your life.
Here's the terrifying part: an estimated one in five people (roughly 20% of the global population) has elevated Lp(a), according to the National Institutes of Health. That's approximately 1.4 billion people worldwide walking around with a significantly increased risk of heart attack, stroke, and aortic valve disease — and most of them have absolutely no idea.
The Numbers That Should Scare You (Just a Little)
My colleague Sandra, who covers health policy and is the kind of person who brings printed PubMed studies to dinner parties (her husband, Greg, has developed a glazed expression that's almost artistic), walked me through the data:
- People with Lp(a) above 50 mg/dL have roughly a 2-3x increased risk of cardiovascular events compared to those with lower levels (NIH/NHLBI research)
- Heart disease kills approximately 695,000 Americans annually — that's 1 in every 5 deaths, according to the CDC
- The standard lipid panel that your doctor orders during a routine checkup does NOT include Lp(a). You have to specifically request it.
- A single Lp(a) test costs between $20-50 and is covered by most insurance plans, yet fewer than 0.5% of adults have ever been tested
"It's like discovering that the smoke alarm in your house has been turned off for 30 years," Sandra said, which is maybe the best analogy I've heard. "The smoke alarm itself — the test — has existed since the 1960s. We just haven't been using it."
What the New Guidelines Actually Say
The new expert guidelines, developed in collaboration with leading cardiologists and lipid specialists, recommend several key changes that CNN described as potentially affecting "millions more people":
- Universal Lp(a) screening — Every adult should have their Lp(a) measured at least once. Because it's genetically determined, one test is usually sufficient.
- Earlier cholesterol management — The guidelines push for cholesterol-lowering medications to be considered as early as a person's 30s for those at elevated risk, down from the traditional focus on patients over 40.
- Family screening — If you have elevated Lp(a), your first-degree relatives (parents, siblings, children) should be tested too, since the trait is inherited.
- Intensified statin therapy — For patients with elevated Lp(a), lower LDL targets may be recommended to compensate for the additional risk.
The Treatment Gap (The Frustrating Part)
Here's where it gets complicated. Tom, my neighbor who's an ER physician (and who once told me that the most dangerous words in medicine are "I feel fine"), put it bluntly during a conversation over the fence last weekend: "We can now tell you that you have this risk factor, but we can't do much about it yet. That's the awkward truth."
Currently, there are no FDA-approved medications specifically designed to lower Lp(a). However, several promising treatments are in late-stage clinical trials:
- Pelacarsen (Novartis) — An antisense oligonucleotide that has shown ability to reduce Lp(a) by up to 80% in Phase 2 trials. Phase 3 results expected in 2026.
- Olpasiran (Amgen) — A small interfering RNA (siRNA) therapy that reduced Lp(a) by over 95% in Phase 2 data published in the New England Journal of Medicine.
- Lepodisiran (Eli Lilly) — Another siRNA approach showing significant Lp(a) reduction in early trials.
"The fact that there's no treatment yet isn't a reason not to test," Sandra argued. "If you know your Lp(a) is high, you can be more aggressive about managing every other modifiable risk factor — blood pressure, LDL, smoking, exercise, weight. Knowledge isn't useless just because one specific drug doesn't exist yet."
What You Should Actually Do on Monday Morning
Rachel, a nurse practitioner who runs a preventive cardiology clinic (and who has this wonderfully direct way of cutting through medical jargon — she once told a patient "your arteries are angry and we need to calm them down"), gave me this practical checklist:
- Call your doctor and ask for an Lp(a) test. Say these exact words: "I'd like to add a lipoprotein-a level to my next blood panel." It's a simple blood draw.
- Know your family history. If a parent, grandparent, or sibling had a heart attack or stroke before age 55 (men) or 65 (women), your risk is already elevated.
- Don't panic if your Lp(a) is high. Elevated Lp(a) increases risk, but it doesn't guarantee an event. It's one factor among many.
- If elevated, push for a coronary calcium score scan. This $100-200 CT scan can show whether plaque has actually built up in your arteries, giving you and your doctor much better risk stratification.
I booked my Lp(a) test for next Tuesday. Dr. Patel seemed surprised when I asked — and then she smiled. "I've been waiting for patients to start asking about this," she said. "It's about time."
Medical Disclaimer: This article references guidelines and studies from the American Heart Association (AHA), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the New England Journal of Medicine. It is not a substitute for professional medical advice. Consult your healthcare provider for personalized recommendations.